Our Board’s mission is to develop strategic priorities for Canadian cancer research funding, track the cancer research investment, and reinforce the value of cancer research by strengthening its research community through funding partnerships, scientific conferences, and reports.

Representatives of patients and families as well as cancer research funding organizations make up the CCRA Board.


Cindy L. Bell, PhD, is the Executive Vice-President, Corporate Development  at Genome Canada.



View Past Chairs